{
  "catalogId": "0600efc2-47f8-4b87-8102-b98f8c39476d",
  "name": "EXEMASIN - VIT",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "156 62 34456 00",
  "treatmentDescriptions": "Exemasin-VIT is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone.Exemasin-VIT is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies. Exemasin-VIT is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "EXEMESTANE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L02BG06",
      "name": "EXEMESTANE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "EXEMASIN - VIT 30 TAB",
      "manufacturer": {
        "name": "ויטאמד",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PVDC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8400"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 217.1922,
        "retailMargin": 17.5,
        "maxRetailPrice": 255.200835,
        "maxPriceWithVAT": 301.1369853
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:42.927779"
  }
}